Eli Lilly weight loss pill orforglipron clears trial, paving way for approval
Eli Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters…
FDA approves Signos glucose monitoring for weight loss
Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever…
Health care CEO salaries, UnitedHealth’s busy week
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
What are PBMs? How a bipartisan push could affect prescriptions
Lawmakers say middlemen in the prescription drug pipeline are limiting access to medications and driving up costs.See the…
Wealthy countries pay more for essential medicines, but the cost burden is far lower, study finds
Published on 17/08/2025 – 9:30 GMT+2 ADVERTISEMENT Wealthy countries may pay steep prices for medicines, but once their…
Novo Nordisk’s obesity drug Wegovy cleared to treat live disease MASH
Novo Nordisk’s obesity drug Wegovy was cleared by U.S. regulators on Friday to treat an increasingly common liver…
Modeling Drug Development Part 2: Post-Approval Development | American Enterprise Institute
July 2025 brought a flicker of hope for people with serious health needs: Congress exempted drugs with multiple…
Doctor exposes shocking disparity in medicine costs between the US, Australia
A doctor has exposed the shocking reality for Americans who are forced to pay up to tens of…
Eli Lilly obesity pill orforglipron led to 12% weight loss
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
Novo Nordisk (NVO) earnings Q2 2025
Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024.…